Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Post COVID .

Open Medicine Foundation (OMF) was founded by Linda Tannenbaum, who currently holds the position of CEO/President. Linda established OMF in 2012 after Linda’s 16-year-old daughter was diagnosed with sudden onset ME / CFS in 2006. Linda was devastated to learn that there were no diagnostic tests or treatments available for the disease that was severely impacting her daughter’s quality of life, and she decided to take action.

Upon conducting extensive research, Linda realized that there was a lack of open, global collaborative research and funding for ME / CFS and related chronic complex diseases. To address this, she founded OMF to raise funds and facilitate large-scale research with the goal of developing diagnostic tools, treatments, and prevention strategies for these diseases.

Linda Tannenbaum is a clinical laboratory scientist with a degree in bacteriology from UCLA. Prior to founding OMF, she ran and co-owned a clinical laboratory for over two decades. Today, Linda’s passion lies in finding a cure for these chronic complex diseases, improving clinical care for patients, and giving millions who suffer from these diseases their lives back.